







Agriculture company Monsanto has acquired a non-exclusive global licensing agreement from MIT’s Broad Institute and Harvard to use the CRISPR/Cas9
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
Over the past decade, the CRISPR-Cas9 gene editing system has revolutionized genetic engineering, allowing scientists to make targeted changes to organisms' DNA. While the system could potentially be ...


Mail-Order CRISPR Kits Allow Absolutely Anyone to Hack DNA
Experts debate what amateur scientists could accomplish with the powerful DNA editing tool—and whether its ready availability is cause for concern

(PDF) Highly efficient genome editing using oocyte-specific z cas9 transgenic zebrafish
PDF | Since its first application, CRISPR/Cas9 rapidly becomes a routine technique to perform genome editing in a variety of biological systems. To... | Find, read and cite all the research you need on ResearchGate

Scientists Have Created A New Gene-Editing Tool That Could Outperform CRISPR
It is faster and simpler than CRISPR, enabling millions of genetic experiments to be performed simultaneously.

'Gene repair' could be tested on people in 2017
Human trials of Crispr editing are being proposed by Massachusetts-based start-up Editas Medicine to treat a rare form of blindness knwon as Leber congenital amaurosis.

UK becomes first country to approve Crispr gene-editing therapy
Sickle cell disease and beta thalassemia are covered by the approval.

On #CRISPR gene drives, the human cost of anti-science, dangers of closed-door science, & more: @kesvelt @ #EAGlobal https://t.co/HLzzOE1Fut
On #CRISPR gene drives, the human cost of anti-science, dangers of closed-door science, & more: @kesvelt @ #EAGlobal https://t.co/HLzzOE1Fut— MIT Media Lab (@medialab) August 24, 2016
It Should Be Legal To Hack Your DNA
A group of geneticists has called for a moratorium on research into modifying heritable human DNA — a practice that could lead to so-called "designer

Ginkgo Bioworks (NYSE:DNA) Trying to Prevent Future Man-Made Biological Threats
Synthetic biology firm Ginkgo Bioworks has developed tools that US intelligence agencies can use to detect engineered DNA at scale, a milestone that could better protect the nation from human-made biological threats. The new software could be used to provide an early warning of bioweapons, such as a new deadly bacteria, or a modified virus that thwarts existing vaccines.

DEF CON 25 - John Sotos - Genetic Diseases to Guide Digital Hacks of the Human Genome
Crispr Could Revolutionize the Way We Eradicate Invasive Species
Gene editing isn't brutal like poison, but it could transform our power over nature.

AI-designed nucleases build on nature’s design
Researchers used AI to create variants of a CRISPR-Cas12-like nuclease, some of which show increased editing activity
Scientists Argue the US Ban on Human Gene Editing Will Leave It Behind - Slashdot
Alex Pearlman, reporting for Motherboard: As the biotech revolution accelerates globally, the U.S. could be getting left behind on key technological advances: namely, human genetic modification. A Congressional ban on human germline modification has "drawn new lines in the sand" on gene editing legi...

Infecting gut microbes with CRISPR-loaded virus demonstrates potential for microbiome gene editing
In a first, researchers at the UC San Francisco have successfully used the DNA-editing system, CRISPR to alter the genomes of bacteria living in the guts of mammals, a development which stands to advance ...

Highly efficient genome editing using oocyte-specific zcas9 transgenic zebrafish. Liu Y, Zhang C, Zhang Y, Lin S, Shi DL, Shao M
Highly efficient genome editing using oocyte-specific zcas9 transgenic zebrafish Since its first application to induce mutations in mammalian cells (Cong et al., 2013; Mali et al., 2013), CRISPR/Cas9 rapidly becomes a routine technique to perform genome editing in a variety of biological systems due to its facile, robust, and multiplexable features (Hwang et al., 2013; Guo et al., 2014; Wang et al., 2013). In every system, Cas9 and sgRNA should co-express to induce mutations. This is typically achieved by injection of the sgRNA mixed with Cas9 mRNA or protein into the fertilized eggs in zebrafish. As the in vivo translation of capped RNAs delay the presence of sufficient Cas9 protein, the mRNA injection produces more mosaic animals and shows relatively lower efficiency when compared to Cas9 protein injection (Burger et al., 2016). However, it is much more cost effective than using commercially available Cas9 protein, especially in the case of large-scale mutation screens. To further simplify this procedure, lower the cost and maintain an acceptable high genome editing efficiency in zebrafish, we set out to generate a transgenic line with stable and specific Cas9 expression in the egg. zpc (zp3b) promoter (zpc0.5) was reported to drive robust and specific GFP expression in the oocyte (Onichtchouk et al., 2003), we thus fused it with a zebrafish codon optimized cas9 (zcas9) followed by an SV40 3' UTR (Fig. 1A and File S1; Liu et al., 2014), and introduced this construct to zebrafish genome by Tol2 mediated transgenesis (Urasaki et al., 2006). To screen female F0 fish harboring this transgene, the F0 female founders were outcrossed with the wild-type male, the resulting eggs were injected with an sgRNA targeting slc45a2 (Moreno-Mateos et al., 2015), a gene essential for melanin synthesis, and assayed for their pigmentation phenotype. We found that the offspring of one founder showed a high proportion of pigmentation defect. Some of them exhibited a homozygous mutant like albino phenotype, suggesting a robust Cas9 expression in the egg and a very high efficient gene disruption. To examine the specificity of zcas9 expression in the transgenic line, the offspring (F1) of this F0 founder were raised to adulthood, and the ovaries of female F1 transgenic fish were dissected and subjected to in situ hybridization (ISH) employing the probe of zcas9. We found that the transcripts of zcas9 were specifically distributed in oocytes with a diameter of 40-200 µm, at around IB-II stages, while in WT embryos, no hybridization signals were detected (Fig. 1B, C). We did not detect zcas9 expression in stage IA oocytes or in larger ones after stage II. Accordingly, by RT-PCR, we also failed